Volume 15, Number 5 (Jul/Aug 2024)
This issue dives into data on the interactions between the gut microbiome and cancers and cancer therapies. Learn how a patient-reported outcome version of the CTCAE measurement system expedited symptom management. Carcinoid heart disease, a rare but potentially life-threatening sequelae of advanced neuroendocrine neoplasm, is highlighted in a case study.
In our online first section, read about how a remote clinical oncology pharmacist nearly doubled average monthly clinical trial enrollment, along with how lung cancer patients and their support partners derived support, advice, and inspiration by engaging in a Facebook community. Get a primer on real-world data and its application, and an overview of oral CDK4/6 inhibitors in breast cancer. Finally, a call to action regarding diversity, equity, and inclusion in multiple myeloma was written by colleagues from the International Myeloma Foundation Nurse Leadership Board.
